Intravitreal triamcinolone effectively manages DMO and increases vision, study reports

The improvement became evident during an average time of 6 months.

Diffractive multifocal IOL linked with progressive decline in vision in aging patients

According to investigators, patients implanted with diffractive multifocal IOLs had notable declines in the corrected distance visual acuity, distance corrected near VA, and near area of focus with aging

Phase 3 NORSE TWO proves ophthalmic bevacizumab effectively treats wet macular degeneration

Dr Firas Rahhal discusses Outlook Therapeutics’ Phase 3 pivotal NORSE TWO trial for ONS-5010.